Advertisement

Topics

Molecular Templates Company Profile

16:25 EST 17th November 2017 | BioPortfolio

Molecular Templates is a biopharmaceutical company focused on the discovery and development of targeted biologic therapeutics using its novel Engineered Toxin Bodies (ETB) platform technology. For more information, visit www.moleculartemplates.com.


News Articles [457 Associated News Articles listed on BioPortfolio]

Takeda and Molecular Templates Collaborate for Next-Generation Oncology Therapies

OSAKA, Japan & AUSTIN, Texas–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE: 4502) and Molecular Templates, Inc. today announced a collaboration agreement for oncology drug...

Takeda begins new R&D link-up with Molecular Templates

Takeda is increasing its R&D investment in oncology with a collaboration with Texas biotech Molecular Templates. The Japanese firm is rebuilding its pipeline under the leadership of CEO Christoph...

Takeda reveals collaboration aimed at bolstering oncology pipeline

It is widely known that Takeda is keen to build its portfolio in oncology and it has made another move to prepare for this after signing a licensing collaboration with Molecular Templates. The researc...

Takeda and Molecular Templates Announce Multi-Target Research and...

The collaboration will apply Molecular Templates' engineered toxin bodies technology platform to potential therapeutic targets provided by Takeda through a joint scientific committee of both compa...

Molecular Templates to Present at the 2017 BIO Investor Forum

AUSTIN, Texas, Oct. 06, 2017 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin B...

Molecular Templates, Inc. Reports Third Quarter 2017 Financial Results

Completed Merger with Threshold Pharmaceuticals in August  Recent Equity Financings of $60 Million Provide Cash Runway into late 2019 MT-3724 Advancing in Clinical Trials with New Data Expected...

Molecular Templates Completes Merger with Threshold Pharmaceuticals and Private Placements

NewsMolecular Templates, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of a new class of targeted biologic therapies that possess unique mechanisms of actio...

Molecular Templates (MTEM) Presents At 2017 BIO Investor Forum - Slideshow

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Nilandron [sanofi-aventis U.S. LLC]

NILANDRON (nilutamide)Tablets

Salsalate [Libertas Pharma, Inc.]

Salsalate Tablets, USP 500 and 750 mgRx Only

PubMed Articles [782 Associated PubMed Articles listed on BioPortfolio]

I-TASSER-MR: automated molecular replacement for distant-homology proteins using iterative fragment assembly and progressive sequence truncation.

Molecular replacement (MR) is one of the most common techniques used for solving the phase problem in X-ray crystal diffraction. The success rate of MR however drops quickly when the sequence identity...

Application of A Novel Three-dimensional Printing Genioplasty Template System and Its Clinical Validation: A Control Study.

The purpose of this control study was to assess the accuracy and clinical validation of a novel genioplasty template system. Eighty-eight patients were enrolled and divided into 2 groups: experimental...

Methods for the computation of templates from quantitative magnetic susceptibility maps (QSM): Toward improved atlas- and voxel-based analyses (VBA).

To develop and assess a method for the creation of templates for voxel-based analysis (VBA) and atlas-based approaches using quantitative magnetic susceptibility mapping (QSM).

NGS-based analysis of base-substitution signatures created by yeast DNA polymerase eta and zeta on undamaged and abasic DNA templates in vitro.

Translesion synthesis (TLS) is the mechanism in which DNA polymerases (TLS polymerases) bypass unrepaired template damage with high error rates. DNA polymerase η and ζ (Polη and Polζ) are major TL...

Generating system-level responses from a network of simple synthetic replicators.

The creation of reaction networks capable of exhibiting responses that are properties of entire systems represents a significant challenge for the chemical sciences. The system-level behavior of a rea...

Clinical Trials [1108 Associated Clinical Trials listed on BioPortfolio]

Study of Medical Student Use of Templates to Document Outpatient Asthma Care in Electronic Medical Record

The purpose of the study is to measure the effectiveness of a social marketing-based medical education intervention on student use of evidence-based templates for documenting outpatient as...

Accuracy of Dental Implant Placement Using Two Different CBCT-derived Templates

The main purpose of the present study is to evaluate the dental implant placement using two different CBCT-derived templates and to study the related factors that affect accuracy so as to ...

The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI

The purpose of this study is to determine ticagrelor combining with low molecular weight heparin is effective and safe during PCI or not.

In Vivo EGFR Molecular Classification

The investigators developed 18F-MPG as a targeted molecular imaging agent for noninvasive and repeatable detecting EGFR-activating mutational status.

Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas

The aim of the planned research project is to find out the clinical significance of molecular genetic analyzes in gynecological malignomas. In particular, it will be investigated how the k...

Companies [845 Associated Companies listed on BioPortfolio]

Molecular Templates

Molecular Templates is a biopharmaceutical company focused on the discovery and development of targeted biologic therapeutics using its novel Engineered Toxin Bodies (ETB) platfor...

Molecular Templates, Inc.

Molecular Templates is a venture-backed biopharmaceutical company focused on the discovery and development of a new class of targeted biologic therapeutics called Engineered Toxin...

Molecular Templates Inc.

Molecular Templates Inc. is creating an entirely new generation of potent anti-cancer agents based on proprietary applied proteomics technologies.The novel therapeutic agents in development by MTI are...

Goldfarb Branham LLP

ABT Molecular Imaging

ABT Molecular Imaging is a medical imaging company marketing its Generator, a production platform which produces unit doses of molecular imaging drugs for positron emission tomogr...

More Information about "Molecular Templates" on BioPortfolio

We have published hundreds of Molecular Templates news stories on BioPortfolio along with dozens of Molecular Templates Clinical Trials and PubMed Articles about Molecular Templates for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Molecular Templates Companies in our database. You can also find out about relevant Molecular Templates Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record